⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10865376 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL892718 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL3195023 | 0.93 | — | — | |
| SCHEMBL177804 | 0.83 | — | — | |
| SCHEMBL2519937 | 0.83 | — | — | |
| SCHEMBL8944307 | 0.83 | — | — | |
| SCHEMBL1068879 | 0.83 | — | — | |
| SCHEMBL5834033 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL5542472 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL5548689 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 305354 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144783-A1 | COMPOSITION FOR PREVENTING OR TREATING PERIPHERAL NEUROPATHY, CONTAINING ISOQUINOLINE DERIVATIVE AS ACTIVE INGREDIENT | ALTMEDICAL CO., LTD. (KR) | 2026-05-28 | — | — | US | claimed |
| EP-4747388-A1 | RECOMBINANT BACTERIAL CELL CAPABLE OF EXPRESSING A HETEROLOGOUS EXTRACELLULAR MATRIX (ECM) DEGRADING POLYPEPTIDE USING A TUMOUR-INDUCIBLE PROMOTER | NEOBE THERAPEUTICS LTD (GB) | 2026-05-27 | — | — | EP | claimed |
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-4746899-A1 | TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH TROP-2 TARGETING ADC | Iovance Biotherapeutics, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747408-A1 | DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER | GENENTECH, INC. (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4746898-A2 | IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| CN-115491690-B | Hydrogen evolution reaction catalyst and preparation method and application thereof | WUHAN HIMALAYA PHOTOELECTRIC TECHNOLOGY Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122075438-A | Synergistic anticancer application of redox responsive coacervate delivery chrysin and 3-methyladenine | — | 2026-05-26 | — | — | CN | claimed |
| US-4536386-A | HIGH DOSAGE OF METOCLOPRAMIDE | A. H. ROBINS COMPANY, INC. (US) | 1985-08-20 | — | — | US | claimed |
| EP-0120907-A1 | PHARMACEUTICAL PREPARATIONS FOR USE IN ANTITUMOUR THERAPY | Aston Molecules Limited (GB) | 1984-10-10 | — | — | EP | claimed |
| EP-0110955-A1 | BRAIN-SPECIFIC DRUG DELIVERY. | UNIV FLORIDA (US) | 1984-06-20 | — | — | EP | claimed |
| US-4451447-A | CISPLATIN, ETHYLENE OXIDE ADDUCT, SODIUM CHLORIDE AND WATER | BRISTOL-MYERS COMPANY (US) | 1984-05-29 | — | — | US | claimed |
| WO-1984001506-A1 | PHARMACEUTICAL PREPARATIONS FOR USE IN ANTITUMOUR THERAPY | UNIV BIRMINGHAM (GB) | 1984-04-26 | — | — | WO | claimed |
| US-4426372-A | SULFIRAM OR DIALKYL DITHIOCARBAMATE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1984-01-17 | — | — | US | claimed |
| WO-1983003968-A1 | BRAIN-SPECIFIC DRUG DELIVERY | UNIVERSITY OF FLORIDA (US) | 1983-11-24 | — | — | WO | claimed |
| US-4322391-A | DISSOLVING IN AN ORGANIC AMIDE, HYDROCHLORIC ACID SOLUTION, PRECIPITATION AND FILTRATION | BRISTOL-MYERS COMPANY (US) | 1982-03-30 | — | — | US | claimed |
| US-4310515-A | INJECTABLE ANTITUMOR AGENT | BRISTOL-MYERS COMPANY (US) | 1982-01-12 | — | — | US | claimed |
| US-4302446-A | MICROCRYSTALLINE CISPLATEN ANTINEOPLASM AGENT | BRISTOL-MYERS COMPANY (US) | 1981-11-24 | — | — | US | claimed |